Información:
Error:
ID
30801
Descripción
Study part: Treatment confirmation. A phase 1 single-masked, randomized (with respect to placebo), placebo-controlled, parallel-group, dose-rising study to evaluate the safety, tolerability and pharmacokinetics of repeat oral doses of GW786034 in elderly healthy volunteers. Trade Name: Votrient. Clinical Study ID: MD1103367.
Palabras clave
Versiones (1)
- 20/6/18 20/6/18 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
20 de junio de 2018
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Treatment confirmation Pazopanib Macular Degeneration MD1103367
Treatment confirmation
- StudyEvent: ODM
Similar models
Treatment confirmation
- StudyEvent: ODM
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
TREATMENT CONFIRMATION (Trt Cont)
C0087111 (UMLS CUI-1)
C0750484 (UMLS CUI-2)
C0750484 (UMLS CUI-2)
Item
Did the subject receive the correct treatment (e.g., treatment which the subject was assigned to) during this dosing interval?
text
C1522541 (UMLS CUI [1])
Code List
Did the subject receive the correct treatment (e.g., treatment which the subject was assigned to) during this dosing interval?
CL Item
Yes (Y)
CL Item
No (N)
reason therapy assigned
Item
When no, record reason
text
C0392360 (UMLS CUI [1,1])
C1522541 (UMLS CUI [1,2])
C1522541 (UMLS CUI [1,2])